Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2001;32:2719-2724
doi: 10.1161/hs1101.098765
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fisher, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisher, C. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Pathology of Stroke
Right arrow Anticoagulants

(Stroke. 2001;32:2719.)
© 2001 American Heart Association, Inc.


Comments, Opinions, and Reviews

A Career in Cerebrovascular Disease

A Personal Account

C. Miller Fisher, MD

From the Department of Neurology, Harvard Medical School, and Neurological Service, Massachusetts General Hospital, Boston, Mass.

Correspondence to Dr C. Miller Fisher, Neurological Service, Massachusetts General Hospital, Fruit Street, Boston, MA 02114-VBK 910.


Key Words: stroke management • stroke, acute • stroke, ischemic • thrombolysis


*    Introduction
 
The Editor, when inviting this piece, thought that an account of my entry into the stroke field and the unfolding of the subsequent studies in cerebrovascular disease would be instructive for the younger readers of Stroke. Be that as it may, knowledge of how a specialty has evolved can be useful in placing present endeavor in perspective. The story is one of clinical and neuropathological studies carried out by one person, an approach now largely superseded.


*    Boston City Hospital
 
In 1949, after my completing a fellowship in Neurology at the Montreal Neurological Institute, Dr Wilder Penfield recommended a year of postgraduate work abroad. Dr Roy Swank, a colleague, insisted that a period of study on the Neurology Service of the Boston City Hospital (BCH) under the direction of Dr Derek Denny-Brown and Dr Raymond D Adams would be unparalleled. Dr Swank placed a telephone call and in a minute or two it was arranged that I spend a year in Neuropathology at BCH under the guidance of Dr Adams. The subject to be investigated was acute hypertensive encephalopathy. A grant-in-aid was received from the Multiple Sclerosis Society. It was for $100.

In 1949 BCH was one of the world’s premier medical centers: 2000 beds and 3 academic medical services, Harvard Medical School, Boston University, and Tufts Medical School. Enthusiasm was the order of the day. The Department of Pathology, including the Section of Neuropathology, comprised the Mallory Institute of Pathology. It was a busy service, with 900 autopsies performed each year. In . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
NeurologyHome page
R. J. Coppola, S.W. Seo, J.H. Heo, K.Y. Lee, W.C. Shin, D.I. Chang, S.M. Kim, and K. Heo
Localization of Claude's syndrome
Neurology, June 11, 2002; 58(11): 1707 - 1708.
[Full Text] [PDF]